Health Care M&A Volume Dropped 19% in Q2:2020, According to HealthCareMandA.com
Health care merger and acquisition activity fell 19% in the second quarter of 2020, to 327 transactions, compared with the previous quarter's 404 announced deals. M&A in the second quarter of 2020 was 33% lower than the same quarter in 2019. Combined spending in the second quarter totaled nearly
The effects of the COVID-19 pandemic on healthcare M&A can be seen in the quarter-over-quarter and year-over-year decline for most of the services sectors. Healthcare services transactions made up 61% of the second quarter's deal volume, lower than the previous quarters. The Behavioral Health Care,
Healthcare technology deals accounted for 39% of the second quarter's deal volume, with 127 transactions. The Biotechnology sector posted a significant year-over-year increase, up 18%, with 39 deals. The race for a COVID-19 vaccine was the focus of several transactions in the second quarter of 2020, giving the sector a boost in activity. Combined spending for all the technology sectors was
"As expected, deal volume in the second quarter was adversely impacted by the coronavirus epidemic," said
"Some analysts were hoping for a rebound in deal activity in Q3 and we are seeing that in some areas," Phillips added. "But with the virus surging in some of the largest states, it will likely be another soft quarter for healthcare deals."
For more information on the HealthCareMandA.com investment research source, or for a membership in any of
Read the full story at https://www.prweb.com/releases/health_care_m_a_volume_dropped_19_in_q2_2020_according_to_healthcaremanda_com/prweb17277801.htm
Sapiens Announces the Launch of its P&C and Reinsurance Core Platform in the DACH Region
Pollution Face Mask with Filter Back in Stock Ahead of Wildfire Smoke Season
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News